News &
Media
-
Who’s Who with NTI: Neurotech Ieads the way in paediatric neurology treatments
View More: Who’s Who with NTI: Neurotech Ieads the way in paediatric neurology treatments -
Neurotech Secures Rare Pediatric Disease Designation for NTI164 in Rett Syndrome
View More: Neurotech Secures Rare Pediatric Disease Designation for NTI164 in Rett Syndrome -
Neurotech scores US FDA rare disease win for NTI164 in Rett syndrome
View More: Neurotech scores US FDA rare disease win for NTI164 in Rett syndrome -
Long Shortz with Neurotech: Dual strategy positions NTI164 for autism and Rett markets
View More: Long Shortz with Neurotech: Dual strategy positions NTI164 for autism and Rett markets -
Stockhead: Dual strategy positions NTI164 for autism and Rett markets
View More: Stockhead: Dual strategy positions NTI164 for autism and Rett markets -
Neurotech advances NTI164 with strong clinical data and new leadership
View More: Neurotech advances NTI164 with strong clinical data and new leadership -
Neurotech launches Authorised Prescriber program for its neurodevelopmental disorders therapy
View More: Neurotech launches Authorised Prescriber program for its neurodevelopmental disorders therapy -
Hope grows as cannabis contender enters the Rett syndrome fight
View More: Hope grows as cannabis contender enters the Rett syndrome fight -
Cannabis-based oil eases symptoms in Rett syndrome girls
View More: Cannabis-based oil eases symptoms in Rett syndrome girls